T S Frank

Summary

Affiliation: Myriad Genetics
Country: USA

Publications

  1. ncbi Sequence analysis of BRCA1 and BRCA2: correlation of mutations with family history and ovarian cancer risk
    T S Frank
    Myriad Genetic Laboratories, Salt Lake City, UT 84108, USA
    J Clin Oncol 16:2417-25. 1998
  2. ncbi Identifying and managing hereditary risk of breast and ovarian cancer
    T S Frank
    Myriad Genetic Laboratories, Salt Lake City, Utah, USA
    Clin Perinatol 28:395-406. 2001
  3. ncbi Clinical characteristics of individuals with germline mutations in BRCA1 and BRCA2: analysis of 10,000 individuals
    Thomas S Frank
    Myriad Genetic Laboratories and Myriad Genetics, Inc, Salt Lake City, UT 84108, USA
    J Clin Oncol 20:1480-90. 2002
  4. ncbi Inherited risk of women's cancers: what's changed for the practicing physician?
    Thomas S Frank
    Myriad Genetic Laboratories, Salt Lake City, Utah, USA
    Clin Obstet Gynecol 45:671-83; discussion 730-2. 2002
  5. ncbi Characterization of common BRCA1 and BRCA2 variants
    Amie M Deffenbaugh
    Myriad Genetic Laboratories, Salt Lake City, UT 84108, USA
    Genet Test 6:119-21. 2002
  6. ncbi Hereditary cancer syndromes
    T S Frank
    Myriad Genetic Laboratories and University of Utah School of Medicine, Salt Lake City, Utah 84108, USA
    Arch Pathol Lab Med 125:85-90. 2001
  7. ncbi Hereditary risk of women's cancers
    Thomas S Frank
    Myriad Genetic Laboratories, Salt Lake City, Utah, USA
    Best Pract Res Clin Obstet Gynaecol 16:703-13. 2002
  8. ncbi BRCA1/2 genetic testing in the community setting
    Wendy Y Chen
    Department of Adult Oncology, Dana Farber Cancer Institute, and Channing Laboratory, Brigham and Women s Hospital and Harvard Medical School, Boston, MA 02115, USA
    J Clin Oncol 20:4485-92. 2002

Detail Information

Publications8

  1. ncbi Sequence analysis of BRCA1 and BRCA2: correlation of mutations with family history and ovarian cancer risk
    T S Frank
    Myriad Genetic Laboratories, Salt Lake City, UT 84108, USA
    J Clin Oncol 16:2417-25. 1998
    ..Previous studies of mutations in BRCA1 or BRCA2 have used detection methods that may underestimate the actual frequency of mutations and have analyzed women using heterogeneous criteria for risk of hereditary cancer...
  2. ncbi Identifying and managing hereditary risk of breast and ovarian cancer
    T S Frank
    Myriad Genetic Laboratories, Salt Lake City, Utah, USA
    Clin Perinatol 28:395-406. 2001
    ..A well-educated community of health care providers and patients can use hereditary risk assessment, including genetic testing, to improve health care...
  3. ncbi Clinical characteristics of individuals with germline mutations in BRCA1 and BRCA2: analysis of 10,000 individuals
    Thomas S Frank
    Myriad Genetic Laboratories and Myriad Genetics, Inc, Salt Lake City, UT 84108, USA
    J Clin Oncol 20:1480-90. 2002
    ..To assess the characteristics that correlate best with the presence of mutations in BRCA1 and BRCA2 in individuals tested in a clinical setting...
  4. ncbi Inherited risk of women's cancers: what's changed for the practicing physician?
    Thomas S Frank
    Myriad Genetic Laboratories, Salt Lake City, Utah, USA
    Clin Obstet Gynecol 45:671-83; discussion 730-2. 2002
  5. ncbi Characterization of common BRCA1 and BRCA2 variants
    Amie M Deffenbaugh
    Myriad Genetic Laboratories, Salt Lake City, UT 84108, USA
    Genet Test 6:119-21. 2002
    ....
  6. ncbi Hereditary cancer syndromes
    T S Frank
    Myriad Genetic Laboratories and University of Utah School of Medicine, Salt Lake City, Utah 84108, USA
    Arch Pathol Lab Med 125:85-90. 2001
    ..CONCLUSIONS: Advances in gene discovery have allowed the diagnosis of recently characterized hereditary cancer syndromes to enhance medical management for individuals with inherited susceptibility to common cancers...
  7. ncbi Hereditary risk of women's cancers
    Thomas S Frank
    Myriad Genetic Laboratories, Salt Lake City, Utah, USA
    Best Pract Res Clin Obstet Gynaecol 16:703-13. 2002
    ....
  8. ncbi BRCA1/2 genetic testing in the community setting
    Wendy Y Chen
    Department of Adult Oncology, Dana Farber Cancer Institute, and Channing Laboratory, Brigham and Women s Hospital and Harvard Medical School, Boston, MA 02115, USA
    J Clin Oncol 20:4485-92. 2002
    ..This study evaluates the process and early outcomes of BRCA1/2 genetic testing as a clinical service in the community setting...